{"id":144,"date":"2006-04-01T00:00:01","date_gmt":"2006-04-01T00:00:01","guid":{"rendered":"https:\/\/awge.doctime.es\/?p=144"},"modified":"2016-05-24T08:24:29","modified_gmt":"2016-05-24T06:24:29","slug":"awge-259","status":"publish","type":"post","link":"https:\/\/awge.doctime.es\/index.php\/2006\/04\/01\/awge-259\/","title":{"rendered":"Preoperative autologous blood donation in primary total knee arthroplasty: a single-centre experience on 214 consecutive patients."},"content":{"rendered":"

vox sang.
\nFranchini M, Regis D, Gandini G, Corallo F, de Gironcoli M, Aprili G.
\nAcceso al enlace publicador<\/a><\/p>\n

BACKGROUND AND OBJECTIVES: Although preoperative autologous blood donation (PABD) is a widespread practice in elective orthopedic surgery, it is controversial whether this procedure avoids allogeneic blood transfusions in patients undergoing total knee arthroplasty (TKA). PATIENTS AND METHODS: We performed a retrospective study on 214 consecutive patients undergoing PABD before elective primary TKA. RESULTS: Thirty-eight patients (17.8%) were transfused with autologous red blood cells (RBC), while four of them (10.5% of those requiring transfusions, 1.9% of all patients) also received allogeneic RBC. The transfused patients were, in most cases, female and had significantly lower basal and preoperative haemoglobin levels. CONCLUSIONS: Based on the results of this study, PABD is not necessary in most patients undergoing TKA, although older female patients with low basal haemoglobin levels could benefit from a predeposit programme and\/or erythropoietin support in order to reduce the risk of exposure to allogeneic blood<\/p>\n","protected":false},"excerpt":{"rendered":"